Press Release

<< Back
November 13, 2014 at 7:00 AM EST

Verastem to Present at the Jefferies 2014 Global Healthcare Conference

BOSTON--(BUSINESS WIRE)--Nov. 13, 2014-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the Jefferies 2014 Global Healthcare Conference on Wednesday, November 19, 2014 at 3:40 p.m. GMT in London.

A live webcast of the presentation can be accessed by visiting the investors section of the Company’s website at www.verastem.com. A replay will be archived on the Verastem website for 90 days following the presentation date.

About Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR and Wnt. For more information, please visit www.verastem.com.

Source: Verastem, Inc.

Verastem, Inc.
Brian Sullivan, 781-292-4212
bsullivan@verastem.com

Investor Contact

getty
John Doyle

VP Investor Relations & Finance
781.292.4279
jdoyle@verastem.com

Joe Rayne

Argot Partners
617.340.6075
joseph@argotpartners.com